ME

23Andme Holding Co

ME.US 23andme.com + Research + Basket
CIK 0001804591
Employees 560
Phone 650 938 6300
Fiscal year end March
IPO Nov 23, 2020
Address 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Price N/A
USD · NASDAQ
52-week range
0.00
0.00
Market Cap
13.34M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
2.35
Div. Yield
N/A
% Institutions
26.08%
% Insiders
17.27%

1 Year

-94.3%

3 Year

-99.2%

10 Year

-99.7%
Description

23andMe Holding Co. operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally. The company operates in two segments, Consumer and Research Services, and Therapeutics. The Consumer and Research Services segment provides personal genome service (PGS) that consists of a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. This segments also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; and offers research services. The Therapeutics segment focuses on the development of novel therapies; and research and development of programs in various therapeutic areas, such as oncology, immunological and inflammatory diseases, and other disease areas, as well as engages in the out-licensing of intellectual property associated with identified drug targets and expenses related to the discovery and development of therapeutic product candidates. This segment also comprises a therapeutics product portfolio, including 23ME-00610 (P006), a humanized monoclonal antibody that interfere with the ability of CD200R1 to interact with CD200 in cancer cells; GSK6097608, an immuno-oncology program for targeting CD96; and 23ME-01473 is an immuno-oncology antibody program that targets the ULBP6 proteins in the NKG2D pathway. The company has collaboration with Mirador Therapeutics to advance mirador's precision medicines for immunology and inflammation. 23andMe Holding Co. was founded in 2006 and is headquartered in South San Francisco, California. On March 23, 2025, 23andMe Holding Co., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Missouri.

Actions

Add an action for ME.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Joseph Selsavage Interim CEO, Chief Financial & Accounting Officer 1964
Ms. Anne Wojcicki Co-Founder & President NA
Mr. Guy Chayoun VP, Interim General Counsel & Corporate Secretary NA
Ms. Tracy Keim Chief Marketing Officer NA
Ms. Savita Pillai Vice President of People NA
Mr. Kent Hillyer Vice President of Consumer Operations 1968
Mr. Daniel Chu Chief Product Officer NA
Mr. Frank Russo Chief Security Officer NA
Mr. Matthew E. Kvarda Chief Restructuring Officer 1972
Mr. Adam Auton Ph.D. Vice President of Human Genetics NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
May 02, 2024 Kathy L Hibbs N/A Sale 1.93K $9.80 $18.88K SEC
Apr 18, 2024 Kathy L Hibbs N/A Sale 1.93K $9.40 $18.11K SEC
Apr 04, 2024 Kathy L Hibbs N/A Sale 1.93K $10.00 $19.27K SEC
Mar 21, 2024 Kathy L Hibbs N/A Sale 1.93K $9.20 $17.73K SEC
Feb 22, 2024 Kathy L Hibbs N/A Sale 1.93K $12.20 $23.51K SEC
Jan 25, 2024 Kathy L Hibbs N/A Sale 1.93K $14.60 $28.13K SEC
Jan 11, 2024 Kathy L Hibbs N/A Sale 1.93K $14.40 $27.75K SEC
Dec 28, 2023 Kathy L Hibbs N/A Sale 1.93K $18.60 $35.84K SEC
Nov 02, 2023 Kathy L Hibbs N/A Sale 1.93K $17.40 $33.53K SEC
Oct 19, 2023 Kathy L Hibbs N/A Sale 1.93K $16.20 $31.22K SEC
Oct 05, 2023 Kathy L Hibbs N/A Sale 1.93K $16.80 $32.37K SEC
Sep 21, 2023 Kathy L Hibbs N/A Sale 1.93K $20.00 $38.54K SEC
Sep 07, 2023 Kathy L Hibbs N/A Sale 2.04K $21.20 $43.33K SEC
Sep 05, 2023 William G Richards N/A Sale 126.00 $21.60 $2.72K SEC
Aug 24, 2023 Kathy L Hibbs N/A Sale 2.04K $21.00 $42.92K SEC
Aug 15, 2023 Kathy L Hibbs N/A Sale 2.04K $26.40 $53.96K SEC
Jul 27, 2023 Kathy L Hibbs N/A Sale 2.04K $37.80 $77.26K SEC
Jul 13, 2023 Kathy L Hibbs N/A Sale 2.04K $36.40 $74.40K SEC
Jun 29, 2023 Kathy L Hibbs N/A Sale 2.04K $34.40 $70.31K SEC
Dec 05, 2022 Kathy L Hibbs N/A Sale 1.31K $65.00 $85.28K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Jane Street Group LLC 257.10K Dec 31, 2024 0.96% $0.00 0.00%
Millennium Management LLC 221.48K Dec 31, 2024 0.83% $0.00 0.00%
Susquehanna International Group, LLP 69.86K Dec 31, 2024 0.26% $0.00 0.00%
XTX Topco Ltd 50.39K Mar 31, 2025 0.19% $0.00 0.00%
Citadel Advisors Llc 49.01K Dec 31, 2024 0.18% $0.00 0.00%
SIMPLEX TRADING, LLC 46.24K Mar 31, 2025 0.17% $0.00 34.03%
Amvescap Plc. 41.55K Dec 31, 2024 0.15% $0.00 0.00%
Northern Trust Corp 29.53K Dec 31, 2024 0.11% $0.00 0.00%
Group One Trading, LP 16.23K Dec 31, 2024 0.06% $0.00 0.00%
UBS Group AG 12.67K Dec 31, 2024 0.05% $0.00 0.00%
Barclays PLC 11.89K Mar 31, 2025 0.04% $0.00 0.00%
Leavell T & Associates Inc 10.00K Dec 31, 2024 0.04% $0.00 0.00%
Steward Partners Investment Advisory, LLC 1.22K Mar 31, 2025 0.00% $0.00 0.00%
Wells Fargo & Co 703.00 Dec 31, 2024 0.00% $0.00 0.00%
TD Waterhouse Canada Inc 575.00 Mar 31, 2025 0.00% $0.00 0.00%
Stonebridge Financial Group, LLC 250.00 Mar 31, 2025 0.00% $0.00 0.00%
Parallel Advisors, LLC 175.00 Mar 31, 2025 0.00% $0.00 250.00%
Banque Transatlantique 50.00 Mar 31, 2025 0.00% $0.00 0.00%
Blue Bell Private Wealth Management, LLC 25.00 Dec 31, 2024 0.00% $0.00 0.00%
IFP Advisors, LLC 25.00 Mar 31, 2025 0.00% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Instl Ttl Stck Mkt Idx Tr 7.90K 0.03% ▲ 0.01% Dec 31, 2024
2 NT Ext Eq Mkt Indx Fd DC Lend T4 3.42K 0.01% ▲ 0.00% Dec 31, 2024
3 NT Ext Eq Mkt Indx Fd DC Lend T3 3.42K 0.01% ▲ 0.00% Dec 31, 2024
4 JHVIT Total Stock Market Index I 402.00 0.00% ▲ 0.00% Mar 31, 2025
5 CIBC US Broad Market Index 384.00 0.00% ▲ 0.00% Jan 31, 2025
6 Knights of Columbus U.S. All Cap Idx I 78.00 0.00% ▲ 21.88% Mar 31, 2025
7 Fidelity Inst TM TPI U.S. All Cap 12.00 0.00% ▲ 140.00% Mar 31, 2025
8 BlackRock Advantage Small Cap Gr Instl 7.00 0.00% ▲ 0.00% Apr 30, 2025

Financial Highlights

▼
Market Cap: $13.34M
EBITDA: $-219.67M
Book Value: $2.35
Earnings/Share: $-17.39
Profit Margin: -186.98%
Operating Margin: -41.87%
ROA (TTM): -33.18%
ROE (TTM): -193.76%
Revenue (TTM): $208.78M
Revenue/Share (TTM): $8.27
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 34.70%

Valuation Metrics

Enterprise Value: $20.23M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 19.72M
Shares Float: 16.10M
% Insiders: 17.27%
% Institutions: 26.08%
Shares Short: 1.79M
Shares Short (Prior Month): 1.70M
Short Ratio: 3.82
Short % Float: 9.43%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$219.64M
Cost of Goods Sold
adjust
$-120.26M
Gross Profit
subtotal
$99.38M
SG&A
adjust
$-148.33M
R&D
adjust
$-205.36M
Other Operating Expense
adjust
$-67.04M
Operating Income
subtotal
$-321.36M
Other / Non-Operating Items
adjust
$-345.35M
Net Income
subtotal
$-666.70M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ME.US!